Preparation Quality Control Department | Hand in hand, build a dream future
How much do you know about ibuprofen sustained-release capsules?
Rundu Co., Ltd. - Isosorbide Mononitrate Sustained-release Capsules passed the drug consistency evaluation
Quality Culture Month Learn GMP well, quality wins people's hearts!
Rundu shares won the highest honor of the 2020 Innovation Zhuhai Science and Technology Awards - Special Prize for Scientific and Technological Progress
Comprehensively improve the quality and efficacy of generic drugs The first batch
China’s Zhejiang Huahai Pharmaceutical set off a global recall after it informed global regulators last month that it had discovered the suspected cancer-causing impurity N-nitrosodimethylamine in its valsartan API after changing its manufacturing process. But the FDA is now reporting that the tainted ingredient may have been on the market for years, not weeks or months.
Finding an antidote for China’s pharmaceutical scandal is proving elusive. Earlier this week, two more Chinese drugmakers recalled blood-pressure products, which had been exported to Taiwan, because of a potential impurity linked to cancer.